Literature DB >> 34746981

The reasons for and mortality of patients unable to receive reimplantation after resection arthroplasty for chronic hip periprosthetic infection.

Yu-Hsuan Lin1, Chao-Jui Chang1, Chih-Wei Chang1, Yi-Chen Chen2, Ta-Wei Tai3,4.   

Abstract

BACKGROUND: Two-stage exchange arthroplasty is a feasible treatment for chronic PJI (periprosthetic joint infection) of total hip arthroplasty (THA). However, there are large numbers of patients who are unable to ultimately receive reimplantation after resection arthroplasty owing to uncontrolled infection and multiple comorbidities. The purpose of the current study was to identify patient-related risk factors and reasons for being unable to undergo revision THA.
METHODS: Individuals undergoing resection arthroplasty for chronic PJI treatment from 2013 to 2020 at our institution were retrospectively reviewed. A variety of patient comorbidities, laboratory data, isolated pathogens, and follow-up status were collected for analysis.
RESULTS: A total of 84 patients (46 men and 38 women) with a 2.7 ± 2.1-year follow-up were analyzed. Thirty-eight (45.2%) patients eventually underwent revision THA, while the other 46 (54.8%) did not receive reimplantation during follow-up. The patients without receiving reimplantation had higher Charlson comorbidity index (CCI) score (3.1 ± 2.9 versus 1.2 ± 1.5; p = 0.001). Lower cumulative incidence of receiving reimplantation was observed in patients with chronic kidney disease (log-rank test, p = 0.019), anemia (p = 0.011), presence of initial fever (p = 0.030), and oxacillin-resistant strain infection (p = 0.030). The most common reasons for not receiving reimplantation were uncontrolled infection, unstable medical conditions, and death. The patients without reimplantation had a relatively higher mortality rate (log-rank test, p = 0.002).
CONCLUSION: Chronic hip PJI with poor medical conditions or oxacillin-resistant strain infection decreased the chance of undergoing revision surgery. These patients had unfavourable outcomes and a higher mortality rate after resection arthroplasty.
© 2021. The Author(s), under exclusive licence to The Author(s) under exclusive licence to SICOT aisbl.

Entities:  

Keywords:  Hip arthroplasty; Periprosthetic joint infection; Reimplantation; Revision; Two-stage exchange arthroplasty

Mesh:

Year:  2021        PMID: 34746981     DOI: 10.1007/s00264-021-05254-4

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

1.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

2.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Douglas R Osmon; Elie F Berbari; Anthony R Berendt; Daniel Lew; Werner Zimmerli; James M Steckelberg; Nalini Rao; Arlen Hanssen; Walter R Wilson
Journal:  Clin Infect Dis       Date:  2012-12-06       Impact factor: 9.079

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Current Trends and Projected Burden of Primary and Revision Total Knee Arthroplasty in Korea Between 2010 and 2030.

Authors:  Tae Woo Kim; Seung-Baik Kang; Chong Bum Chang; Sun-Young Moon; Young-Kyun Lee; Kyung-Hoi Koo
Journal:  J Arthroplasty       Date:  2020-07-01       Impact factor: 4.757

5.  Increased periprosthetic hip and knee infection projected from 2014 to 2035 in Taiwan.

Authors:  Chih-Hsiang Chang; Sheng-Hsun Lee; Yu-Chih Lin; Yi-Chun Wang; Chee-Jen Chang; Pang-Hsin Hsieh
Journal:  J Infect Public Health       Date:  2020-05-21       Impact factor: 3.718

6.  Periprosthetic Infection Recurrence After 2-Stage Exchange Arthroplasty: Failure or Fate?

Authors:  Georgios K Triantafyllopoulos; Stavros G Memtsoudis; Wei Zhang; Yan Ma; Thomas P Sculco; Lazaros A Poultsides
Journal:  J Arthroplasty       Date:  2016-08-24       Impact factor: 4.757

7.  90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis.

Authors:  Linda P Hunt; Yoav Ben-Shlomo; Emma M Clark; Paul Dieppe; Andrew Judge; Alex J MacGregor; Jon H Tobias; Kelly Vernon; Ashley W Blom
Journal:  Lancet       Date:  2013-09-28       Impact factor: 79.321

8.  Economic burden of periprosthetic joint infection in the United States.

Authors:  Steven M Kurtz; Edmund Lau; Heather Watson; Jordana K Schmier; Javad Parvizi
Journal:  J Arthroplasty       Date:  2012-05-02       Impact factor: 4.757

9.  Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years.

Authors:  Szu-Yuan Chen; Chi-Chien Hu; Chun-Chieh Chen; Yu-Han Chang; Pang-Hsin Hsieh
Journal:  Biomed Res Int       Date:  2015-04-29       Impact factor: 3.411

10.  Temporal trends in primary and revision total knee and hip replacement in Taiwan.

Authors:  Atul Kumar; Wen-Chen Tsai; Tai-Sheng Tan; Pei-Tseng Kung; Li-Ting Chiu; Ming-Chou Ku
Journal:  J Chin Med Assoc       Date:  2015-08-28       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.